Stay updated on Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.

Latest updates to the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 has been added, and a funding-status notice was removed; these are minor site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding status notice was added. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and updated metadata to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page’s revision label was updated from v3.3.3 to v3.3.4; no study content, eligibility criteria, or navigation elements appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section includes Massachusetts as a location, replacing the previous Massachusetts Locations heading; the page version is updated to v3.3.3 and the HHS Vulnerability Disclosure link in the footer was removed.SummaryDifference0.2%

- Check91 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. No visible changes to the study details, eligibility criteria, or trial status.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.